These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1647394)

  • 1. Inhibition of virus-induced cell fusion by apolipoprotein A-I and its amphipathic peptide analogs.
    Srinivas RV; Venkatachalapathi YV; Rui Z; Owens RJ; Gupta KB; Srinivas SK; Anantharamaiah GM; Segrest JP; Compans RW
    J Cell Biochem; 1991 Feb; 45(2):224-37. PubMed ID: 1647394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs.
    Srinivas RV; Birkedal B; Owens RJ; Anantharamaiah GM; Segrest JP; Compans RW
    Virology; 1990 May; 176(1):48-57. PubMed ID: 2158697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The physiological function of plasma apoA-I--the anti-viral effects of apoA-I and its fragments].
    Hu G; Chen B; Yan X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):98-103. PubMed ID: 7987949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.
    Owens BJ; Anantharamaiah GM; Kahlon JB; Srinivas RV; Compans RW; Segrest JP
    J Clin Invest; 1990 Oct; 86(4):1142-50. PubMed ID: 2170446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of model class A1, class A2, and class Y amphipathic helical peptides with membranes.
    Mishra VK; Palgunachari MN
    Biochemistry; 1996 Aug; 35(34):11210-20. PubMed ID: 8780526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine.
    Anantharamaiah GM; Jones JL; Brouillette CG; Schmidt CF; Chung BH; Hughes TA; Bhown AS; Segrest JP
    J Biol Chem; 1985 Aug; 260(18):10248-55. PubMed ID: 4019510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
    Anantharamaiah GM; Garber DW; White CR
    Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
    Zhu HL; Atkinson D
    Biochemistry; 2004 Oct; 43(41):13156-64. PubMed ID: 15476409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amino acid distribution of amphipathic helical peptide derived from human apolipoprotein A-I on membrane curvature sensing.
    Tanaka M; Takamura Y; Kawakami T; Aimoto S; Saito H; Mukai T
    FEBS Lett; 2013 Mar; 587(5):510-5. PubMed ID: 23347831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein/lipid interactions: studies with synthetic polypeptides.
    Sparrow JT; Gotto AM
    CRC Crit Rev Biochem; 1982; 13(1):87-107. PubMed ID: 6813024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
    Johnson JE; Rao NM; Hui SW; Cornell RB
    Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly.
    Palgunachari MN; Mishra VK; Lund-Katz S; Phillips MC; Adeyeye SO; Alluri S; Anantharamaiah GM; Segrest JP
    Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):328-38. PubMed ID: 8620350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
    Zhu HL; Atkinson D
    Biochemistry; 2007 Feb; 46(6):1624-34. PubMed ID: 17279626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lipid-binding properties of the N-terminal helical segments in human apolipoprotein A-I using fragment peptides.
    Tanaka M; Tanaka T; Ohta S; Kawakami T; Konno H; Akaji K; Aimoto S; Saito H
    J Pept Sci; 2009 Jan; 15(1):36-42. PubMed ID: 19048603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branched synthetic constructs that mimic the physico-chemical properties of apolipoprotein AI in reconstituted high-density lipoproteins.
    Demoor L; Boutillon C; Fievet C; Vanloo B; Baert J; Rosseneu M; Fruchart JC; Tartar A
    Eur J Biochem; 1996 Jul; 239(1):74-84. PubMed ID: 8706721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
    Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
    J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interfacial properties of ApoA-I and an amphipathic alpha-helix consensus peptide of exchangeable apolipoproteins at the triolein/water interface.
    Wang L; Atkinson D; Small DM
    J Biol Chem; 2005 Feb; 280(6):4154-65. PubMed ID: 15695525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of single amino acid E235 affects the structure and lipid interaction of human apolipoprotein A-I C-terminal peptides.
    Tanaka T; Tanaka M; Sugiura M; Kawakami T; Aimoto S; Saito H
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):499-503. PubMed ID: 19420782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.
    Mishra VK; Palgunachari MN; Datta G; Phillips MC; Lund-Katz S; Adeyeye SO; Segrest JP; Anantharamaiah GM
    Biochemistry; 1998 Jul; 37(28):10313-24. PubMed ID: 9665740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose.
    Carballo-Jane E; Chen Z; O'Neill E; Wang J; Burton C; Chang CH; Chen X; Eveland S; Frantz-Wattley B; Gagen K; Hubbard B; Ichetovkin M; Luell S; Meurer R; Song X; Strack A; Langella A; Cianetti S; Rech F; Capitò E; Bufali S; Veneziano M; Verdirame M; Bonelli F; Monteagudo E; Pessi A; Ingenito R; Bianchi E
    Bioorg Med Chem; 2010 Dec; 18(24):8669-78. PubMed ID: 21115285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.